An extension to a phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome-positive leukemia including acute lymphoblastic leukaemia, acute m...

Update Il y a 5 ans
Reference: EUCTR2004-001396-19

An extension to a phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome-positive leukemia including acute lymphoblastic leukaemia, acute myeloid leukaemia, and accelerated phase chronic myeloid leukemia

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

•To enable patients to have access to study drug and continue study treatment •To decrease data collection to include overall survival and serious adverse events


Inclusion criteria

  • Philadelphia chromosome-opositive chronic myeloid leukamia in myeloid blast crisis

Links